VVOS logo
VVOS
Vivos Therapeutics

Acquisitions And Sleep Center Integrations Will Expand Future Markets

Published
15 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$4.23
1.1% overvalued intrinsic discount
15 Aug
US$4.27
Loading
1Y
40.0%
7D
-10.1%

Author's Valuation

US$4.2

1.1% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates2

Shared on01 May 25
Fair value Decreased 23%

Read more

Shared on24 Apr 25
Fair value Decreased 5.96%

AnalystConsensusTarget has decreased revenue growth from 22.2% to 17.5%.

Read more